Tri-lo-marzia Kit
Product Images NDC 68180-837

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tri-lo-marzia (NDC 68180-837). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Wallet (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 01)

An instructional diagram for a 28-day oral contraceptive pack showing a weekly calendar layout with labeled days (Sunday to Saturday) across four rows representing weeks 1 to 4. The diagram includes a guide to start on Sunday and instructions for placing a day label strip if the period starts on a different day. A reminder for a monthly self-breast exam is indicated on the right side.*

FDA Label Image

Image (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 02)

A forest plot titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' displays effect estimates (Odds Ratio/Relative Risk) from multiple studies. The horizontal axis ranges from -1.5 to 2, showing each study's point estimate with confidence intervals plotted against a vertical line at 1. Study names and years are listed on the left, with corresponding numeric effect estimates and confidence intervals on the right.*

FDA Label Image

Image Structure (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 03)

Chemical structure diagrams of the active ingredients Norgestimate and Ethinyl Estradiol, showing their molecular frameworks and structural formulas as part of the drug TRI-LO-MARZIA by Lupin Pharmaceuticals, Inc.*

FDA Label Image

Image Med Guide (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 04)

An effectiveness chart for birth control methods showing pregnancy rates per 100 women per year. It ranks methods from fewer pregnancies (implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones) to more pregnancies (condoms, diaphragm, abstinence during fertile days, spermicide, withdrawal) and no birth control leading to the most pregnancies.*

FDA Label Image

Image A-w Wallet (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 05)

Illustration of a weekly pill-taking schedule for TRI-LO-MARZIA oral contraceptive tablets. It shows four rows labeled Week 1 to Week 4, each with seven circular day markers from Sunday to Saturday, arranged left to right, indicating daily pill intake order. Arrows between days guide progression, and there is a note about starting on a day other than Sunday and a reminder for monthly self breast exams on the right side.*

FDA Label Image

Wallet (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 06)

TRI-LO-MARZIA tablet blister label showing medication identification with active ingredients norgestimate and ethinyl estradiol in three strengths (0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg). The label includes storage instructions and distribution by Lupin Pharmaceuticals, Inc., and manufacturing by Lupin Limited in India. The back side of the label depicts a 4-week daily pill calendar with days of the week and weekly rows, plus a monthly self-breast exam reminder.*

FDA Label Image

Pouch (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 07)

Label for TRI-LO-MARZIA tablets by Lupin Pharmaceuticals, Inc. The product contains norgestimate and ethinyl estradiol tablets USP with multiple strengths listed: 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg. The label states it is for prescription use only and includes one blister pack of 28 tablets. The label also warns it is intended to prevent pregnancy but does not protect against HIV or other sexually transmitted diseases.*

FDA Label Image

Carton (30faa5f4 F67a 4eaa A99a 6d56fbcd8e5f 08)

The packaging label for TRI-LO-MARZIA tablets by Lupin Pharmaceuticals, Inc. displays the product name and active ingredients—norgestimate and ethinyl estradiol tablets USP—in strengths of 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg. The label specifies a package containing 3 blisters of 28 tablets each and includes batch and manufacturer details. It also states the medication is for contraception, with a warning that it does not protect against HIV/AIDS and other sexually transmitted diseases.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.